Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mireille Van Gele

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Molecular Cancer|September 24, 2010
P-cadherin counteracts myosin II-B function: implications in melanoma progressionKoen Jacobs, Mireille Van Gele, Ramses Forsyth, et al.
International Journal of Oncology|February 14, 2013
miR-145 overexpression suppresses the migration and invasion of metastatic melanoma cellsPeter Dynoodt, Reinhart Speeckaert, Olivier De Wever, et al.
Experimental Dermatology|June 29, 2011
Development of a 3D pigmented skin model to evaluate RNAi-induced depigmentationMireille Van Gele, Barbara Geusens, Reinhart Speeckaert, et al.
Plos One|August 17, 2013
Characterization of Staphylococcus and Corynebacterium clusters in the human axillary regionChris Callewaert, Frederiek-Maarten Kerckhof, Michael S Granitsiotis, et al.
Plos One|October 7, 2016
JAK3 as an Emerging Target for Topical Treatment of Inflammatory Skin DiseasesAna Karina Alves de Medeiros, Reinhart Speeckaert, Eline Desmet, et al.
Journal of Translational Medicine|February 1, 2017
A phase II trial of stereotactic body radiotherapy with concurrent anti-PD1 treatment in metastatic melanoma: evaluation of clinical and immunologic responseKatrien De Wolf, Vibeke Kruse, Nora Sundahl, et al.
Oncoimmunology|July 4, 2012
Immune mediated mechanisms of melanocyte destruction: Paving the way for efficient immunotherapeutic strategies against melanomaReinhart Speeckaert, Nanja Van Geel, Jo Lambert, et al.
International Journal of Cancer|September 5, 2002
Proneural and proneuroendocrine transcription factor expression in cutaneous mechanoreceptor (Merkel) cells and Merkel cell carcinomaJ Helen Leonard, Anthony L Cook, Mireille Van Gele, et al.
Journal of Translational Medicine|January 17, 2015
Clinical significance of plasmacytoid dendritic cells and myeloid-derived suppressor cells in melanomaInes Chevolet, Reinhart Speeckaert, Max Schreuer, et al.
International Journal of Pharmaceutics|January 26, 2016
An elastic liposomal formulation for RNAi-based topical treatment of skin disorders: Proof-of-concept in the treatment of psoriasisEline Desmet, Stefanie Bracke, Katrien Forier, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Molecular Cancer|September 24, 2010
P-cadherin counteracts myosin II-B function: implications in melanoma progressionKoen Jacobs, Mireille Van Gele, Ramses Forsyth, et al.
International Journal of Oncology|February 14, 2013
miR-145 overexpression suppresses the migration and invasion of metastatic melanoma cellsPeter Dynoodt, Reinhart Speeckaert, Olivier De Wever, et al.
Experimental Dermatology|June 29, 2011
Development of a 3D pigmented skin model to evaluate RNAi-induced depigmentationMireille Van Gele, Barbara Geusens, Reinhart Speeckaert, et al.
Plos One|August 17, 2013
Characterization of Staphylococcus and Corynebacterium clusters in the human axillary regionChris Callewaert, Frederiek-Maarten Kerckhof, Michael S Granitsiotis, et al.
Plos One|October 7, 2016
JAK3 as an Emerging Target for Topical Treatment of Inflammatory Skin DiseasesAna Karina Alves de Medeiros, Reinhart Speeckaert, Eline Desmet, et al.
Journal of Translational Medicine|February 1, 2017
A phase II trial of stereotactic body radiotherapy with concurrent anti-PD1 treatment in metastatic melanoma: evaluation of clinical and immunologic responseKatrien De Wolf, Vibeke Kruse, Nora Sundahl, et al.
Oncoimmunology|July 4, 2012
Immune mediated mechanisms of melanocyte destruction: Paving the way for efficient immunotherapeutic strategies against melanomaReinhart Speeckaert, Nanja Van Geel, Jo Lambert, et al.
International Journal of Cancer|September 5, 2002
Proneural and proneuroendocrine transcription factor expression in cutaneous mechanoreceptor (Merkel) cells and Merkel cell carcinomaJ Helen Leonard, Anthony L Cook, Mireille Van Gele, et al.
Journal of Translational Medicine|January 17, 2015
Clinical significance of plasmacytoid dendritic cells and myeloid-derived suppressor cells in melanomaInes Chevolet, Reinhart Speeckaert, Max Schreuer, et al.
International Journal of Pharmaceutics|January 26, 2016
An elastic liposomal formulation for RNAi-based topical treatment of skin disorders: Proof-of-concept in the treatment of psoriasisEline Desmet, Stefanie Bracke, Katrien Forier, et al.
Pageof 4